{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:18:10Z","timestamp":1792174690206,"version":"4.4.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2012M3A9B6055466"],"award-info":[{"award-number":["2012M3A9B6055466"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2011-0030074"],"award-info":[{"award-number":["2011-0030074"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015R1D1A1A01056594"],"award-info":[{"award-number":["NRF-2015R1D1A1A01056594"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162335","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T13:46:17Z","timestamp":1473428777000},"page":"e0162335","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["ATM\/CHK\/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene"],"prefix":"10.1371","volume":"11","author":[{"given":"Hani","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ha","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-6906","authenticated-orcid":true,"given":"Woo-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"issue":"4","key":"ref1","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"CE DeSantis","year":"2014","journal-title":"CA: a cancer journal for clinicians"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0169-5002(05)80093-5","article-title":"Lung premalignancy and chemoprevention","volume":"49","author":"WK Hong","year":"2005","journal-title":"Lung Cancer"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3322\/canjclin.54.3.150","article-title":"Chemoprevention of cancer","volume":"54","author":"AS Tsao","year":"2004","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(03)01244-0","article-title":"Chemoprevention of lung cancer","volume":"4","author":"JC Soria","year":"2003","journal-title":"Lancet Oncology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1006\/gyno.2002.6685","article-title":"General keynote: The impact of cancer chemoprevention","volume":"88","author":"WK Hong","year":"2003","journal-title":"Gynecologic Oncology"},{"issue":"10","key":"ref6","first-page":"1244s","article-title":"Molecularly therapeutic approaches to lung cancer chemoprevention","volume":"11","author":"FR Khuri","year":"2002","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrc2674","article-title":"Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers","volume":"9","author":"SS Hecht","year":"2009","journal-title":"Nature reviews Cancer"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ejca.2005.05.011","article-title":"Chemoprevention in lung carcinogenesis\u2014an overview","volume":"41","author":"N van Zandwijk","year":"2005","journal-title":"European journal of cancer"},{"issue":"1 Suppl","key":"ref9","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1378\/chest.103.1_Supplement.15S","article-title":"Chemoprevention strategies in lung carcinogenesis","volume":"103","author":"SM Lippman","year":"1993","journal-title":"Chest"},{"issue":"Suppl 1","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01635581.2013.785012","article-title":"Introduction to Special Issue on Molecular Basis for Cancer Prevention with Bioactive Food Components in Nutrition and Cancer\u2014an International Journal","volume":"65","author":"R Agarwal","year":"2013","journal-title":"Nutrition and cancer"},{"issue":"11 Suppl 1","key":"ref11","doi-asserted-by":"crossref","first-page":"3837S","DOI":"10.1093\/jn\/133.11.3837S","article-title":"Defining the state of knowledge with respect to food, nutrition, physical activity, and the prevention of cancer","volume":"133","author":"SJ Heggie","year":"2003","journal-title":"The Journal of nutrition"},{"issue":"6","key":"ref12","first-page":"523","article-title":"Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research\/World Cancer Research Fund, American Institute for Cancer Research, 1997","volume":"15","author":"MJ Glade","year":"1999","journal-title":"Nutrition"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mrrev.2011.07.005","article-title":"Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy","volume":"728","author":"D Nambiar","year":"2011","journal-title":"Mutat Res"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mnfr.200600257","article-title":"Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process","volume":"51","author":"SJ Duthie","year":"2007","journal-title":"Molecular nutrition & food research"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/carcin\/bgq101","article-title":"p53 is balancing development, differentiation and de-differentiation to assure cancer prevention","volume":"31","author":"A Molchadsky","year":"2010","journal-title":"Carcinogenesis"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/mt.2009.268","article-title":"Prevention of senescence progression in reversibly immortalized human ensheathing glia permits their survival after deimmortalization","volume":"18","author":"V Garcia-Escudero","year":"2010","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/138161211795222595","article-title":"Pharmacological activation of p53 in cancer cells","volume":"17","author":"M Athar","year":"2011","journal-title":"Current pharmaceutical design"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10408363.2013.805182","article-title":"Pterostilbene: Biomedical applications","volume":"50","author":"JM Estrela","year":"2013","journal-title":"Critical reviews in clinical laboratory sciences"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1039\/c2np20049j","article-title":"Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae","volume":"29","author":"C Riviere","year":"2012","journal-title":"Natural product reports"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.jss.2011.09.054","article-title":"Pterostilbene and cancer: current review","volume":"173","author":"D McCormack","year":"2012","journal-title":"J Surg Res"},{"issue":"14","key":"ref21","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1073\/pnas.1114278109","article-title":"High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death","volume":"109","author":"JT Fox","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1017\/S0007114509990481","article-title":"The red wine polyphenol resveratrol reduces polycyclic aromatic hydrocarbon-induced DNA damage in MCF-10A cells","volume":"102","author":"HY Leung","year":"2009","journal-title":"The British journal of nutrition"},{"issue":"3","key":"ref23","first-page":"429","article-title":"The genotoxicity study of resveratrol in primary gastric adenocarcinoma cell cultures","volume":"50","author":"P Mitrut","year":"2009","journal-title":"Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie"},{"issue":"1\u20132","key":"ref24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mrfmmm.2005.01.029","article-title":"Genotoxicity of phytoestrogens","volume":"574","author":"H Stopper","year":"2005","journal-title":"Mutation research"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2010.02.022","article-title":"Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction","volume":"295","author":"S Leone","year":"2010","journal-title":"Cancer Lett"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1002\/ijc.27358","article-title":"Resveratrol acts as a topoisomerase II poison in human glioma cells","volume":"131","author":"S Leone","year":"2012","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2010.02.022","article-title":"Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction","volume":"295","author":"S Leone","year":"2010","journal-title":"Cancer letters"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrm1493","article-title":"Checking on DNA damage in S phase","volume":"5","author":"J Bartek","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6811","key":"ref29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: putting checkpoints in perspective","volume":"408","author":"BB Zhou","year":"2000","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"J Smith","year":"2010","journal-title":"Advances in cancer research"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.4161\/cc.10.19.17460","article-title":"Genotoxic stress-mediated cell cycle activities for the decision of cellular fate","volume":"10","author":"A Erol","year":"2011","journal-title":"Cell cycle"},{"issue":"56","key":"ref32","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1038\/sj.onc.1210881","article-title":"DNA damage signalling guards against activated oncogenes and tumour progression","volume":"26","author":"J Bartek","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.molcel.2010.01.021","article-title":"Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair","volume":"37","author":"E Petermann","year":"2010","journal-title":"Molecular cell"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/ptr.5442","article-title":"Stilbenoids from Rheum undulatum Protect Hepatocytes Against Oxidative Stress Through AMPK Activation","volume":"29","author":"GZ Dong","year":"2015","journal-title":"Phytother Res"},{"issue":"20","key":"ref35","first-page":"8216","article-title":"Elevated Epithelial Insulin-Like Growth Factor Expression Is a Risk Factor for Lung Cancer Development (vol 69, pg 7439, 2009)","volume":"69","author":"WY Kim","year":"2009","journal-title":"Cancer Research"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-05-2521","article-title":"Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells","volume":"66","author":"M Sato","year":"2006","journal-title":"Cancer Res"},{"issue":"24","key":"ref37","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1158\/0008-5472.CAN-04-3703","article-title":"Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins","volume":"64","author":"RD Ramirez","year":"2004","journal-title":"Cancer research"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/nprot.2009.191","article-title":"Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo","volume":"4","author":"F Debacq-Chainiaux","year":"2009","journal-title":"Nat Protoc"},{"issue":"20","key":"ref39","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"GP Dimri","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"575482","DOI":"10.1155\/2013\/575482","article-title":"A review of pterostilbene antioxidant activity and disease modification","volume":"2013","author":"D McCormack","year":"2013","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.jss.2011.09.054","article-title":"Pterostilbene and cancer: current review","volume":"173","author":"D McCormack","year":"2012","journal-title":"The Journal of surgical research"},{"issue":"25","key":"ref42","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1021\/jf301499e","article-title":"Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells","volume":"60","author":"VC Lin","year":"2012","journal-title":"J Agric Food Chem"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"e6944","DOI":"10.1371\/journal.pone.0006944","article-title":"The role of specific checkpoint-induced S-phase transcripts in resistance to replicative stress","volume":"4","author":"C Dutta","year":"2009","journal-title":"PLoS One"},{"issue":"14","key":"ref44","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0401238101","article-title":"RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies","volume":"101","author":"VI Kashuba","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.dnarep.2009.04.011","article-title":"Targeting the DNA damage response for cancer therapy","volume":"8","author":"SN Powell","year":"2009","journal-title":"DNA Repair (Amst)"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-05-2521","article-title":"Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells","volume":"66","author":"M Sato","year":"2006","journal-title":"Cancer Res"},{"issue":"51","key":"ref47","doi-asserted-by":"crossref","first-page":"47759","DOI":"10.1074\/jbc.C100569200","article-title":"Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress","volume":"276","author":"IM Ward","year":"2001","journal-title":"J Biol Chem"},{"issue":"19","key":"ref48","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1021\/jf071520h","article-title":"Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells","volume":"55","author":"MH Pan","year":"2007","journal-title":"J Agric Food Chem"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcancer.2004.08.005","article-title":"Origins and selection of p53 mutations in lung carcinogenesis","volume":"15","author":"SN Rodin","year":"2005","journal-title":"Seminars in cancer biology"},{"issue":"45","key":"ref50","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1038\/sj.onc.1205563","article-title":"The p53 network in lung carcinogenesis","volume":"21","author":"AI Robles","year":"2002","journal-title":"Oncogene"},{"issue":"5142","key":"ref51","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1126\/science.8266092","article-title":"p53: at the crossroads of molecular carcinogenesis and risk assessment","volume":"262","author":"CC Harris","year":"1993","journal-title":"Science"},{"issue":"2","key":"ref52","first-page":"127","article-title":"Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer","volume":"9","author":"GJ Kelloff","year":"2000","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"ref53","article-title":"Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition","author":"LR Ferguson","year":"2015","journal-title":"Seminars in cancer biology"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexcr.2014.09.030","article-title":"DNA replication stress: causes, resolution and disease","volume":"329","author":"A Mazouzi","year":"2014","journal-title":"Experimental cell research"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"e105342","DOI":"10.1371\/journal.pone.0105342","article-title":"Pterostilbene simultaneously induced G0\/G1-phase arrest and MAPK-mediated mitochondrial-derived apoptosis in human acute myeloid leukemia cell lines","volume":"9","author":"PC Hsiao","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ncb2201","article-title":"53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress","volume":"13","author":"C Lukas","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"7035","key":"ref57","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"J Bartkova","year":"2005","journal-title":"Nature"},{"issue":"7035","key":"ref58","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"VG Gorgoulis","year":"2005","journal-title":"Nature"},{"issue":"33","key":"ref59","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1200\/JCO.2013.51.2400","article-title":"Challenge and opportunity of targeted lung cancer chemoprevention","volume":"31","author":"SM Dubinett","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T05:51:15Z","timestamp":1568353875000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162335"}},"subtitle":[],"editor":[{"given":"Thomas G","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162335","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}